Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Revenue: 2023-2025

Historic Revenue for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $683,000.

  • Upstream Bio's Revenue rose 12.52% to $683,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 26.82%. This contributed to the annual value of $2.4 million for FY2024, which is 0.42% down from last year.
  • Per Upstream Bio's latest filing, its Revenue stood at $683,000 for Q3 2025, which was down 27.11% from $937,000 recorded in Q2 2025.
  • Upstream Bio's 5-year Revenue high stood at $937,000 for Q2 2025, and its period low was $450,000 during Q4 2023.
  • Moreover, its 3-year median value for Revenue was $613,000 (2024), whereas its average is $625,222.
  • The largest annual percentage gain for Upstream Bio's Revenue in the last 5 years was 83.73% (2025), contrasted with its biggest fall of 11.56% (2025).
  • Upstream Bio's Revenue (Quarterly) stood at $450,000 in 2023, then spiked by 36.22% to $613,000 in 2024, then increased by 12.52% to $683,000 in 2025.
  • Its last three reported values are $683,000 in Q3 2025, $937,000 for Q2 2025, and $566,000 during Q1 2025.